HIV Reservoir Dynamics After Switching to Dolutegravir in Patients With Two NRTI and a Protease Inhibitor Based Regimen. A Phase IV Open Randomized Trial.
Phase of Trial: Phase IV
Latest Information Update: 17 Jun 2017
At a glance
- Drugs Dolutegravir (Primary) ; Atazanavir; Darunavir; Fosamprenavir; Lopinavir
- Indications HIV-1 infections
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 13 Jun 2017 Status changed from active, no longer recruiting to completed.
- 06 Jun 2016 Planned End Date changed from 1 Jun 2016 to 1 Nov 2016.